FASLG and neoplasm: Tumor cells also induce the expression of FasL in endothelial cells via vascular endothelial growth factor-A (VEGF-A), IL-10, and prostaglandin E2 (PGE2), thereby eliciting specific cytotoxic effects in effector T cells (61).